How many mg is 70 units of tirzepatide — and why the question itself reveals a common mix-up

Tirzepatide (Mounjaro) is dosed in milligrams, not units — the two systems are not interchangeable and no safe conversion exists between them.
The licensed Mounjaro strengths in the UK are 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg, each delivered via a pre-filled KwikPen.
"Units" is the measurement system for insulin; mixing up the two frameworks is a recognised patient-safety risk flagged by prescribers.
Dose decisions (including any adjustment) are made by a GPhC-registered prescriber following clinical review, never calculated by the patient from unit markings.

Seventy units of tirzepatide does not correspond to a licensed Mounjaro dose. Tirzepatide is measured in milligrams, not units (the doses are 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg) and the "units" framing almost always signals confusion with insulin, which is measured that way. If you've seen a syringe marked in units and wondered how it maps to your Mounjaro pen, the short answer is: it doesn't, and it shouldn't. Mounjaro is a prescription-only medicine and the dose your prescriber sets is the only one that applies to you; the Patient Information Leaflet and your prescriber are the right sources for any specific dosing question.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Why the mg-versus-units question matters for Mounjaro safety

The misconception: thinking tirzepatide can be drawn up and measured in units

The biggest misunderstanding behind this search is a reasonable one. Insulin has been measured in units for decades, and many people who manage diabetes or live with someone who does are familiar with insulin pens, syringes graduated in units, and instructions written in units. When a new injectable medicine arrives, it's natural to reach for the same mental framework.

Tirzepatide doesn't fit that framework at all. Mounjaro is supplied as a pre-filled, single-patient KwikPen, each pen contains four weekly doses, already set by the manufacturer at a fixed concentration. You do not draw up tirzepatide into a syringe. You do not count units. The pen delivers the dose when you press the button. There is no dial, no plunger, no graduation markings in units to misread.

The concern is that people who do try to draw tirzepatide from a vial into an insulin syringe (which has happened with compounded or counterfeit products) are working with a completely different concentration system and risk catastrophic dosing errors. The MHRA has warned publicly about fake weight-loss pens, and any product requiring you to measure units of tirzepatide yourself is a serious red flag. You can report suspect sellers through the MHRA Yellow Card scheme.

What 70 units actually means, and why it has no mg equivalent for tirzepatide

For insulin, one "unit" is a standardised biological measure tied to insulin's specific activity. The number of milligrams of insulin in one unit varies by formulation, but the unit itself is a consistent way to describe insulin's effect.

Tirzepatide is not insulin. It's a dual GIP and GLP-1 receptor agonist, the only one of its kind licensed for weight management in the UK. Its doses are fixed in milligrams and set by clinical trial evidence, regulatory review and SmPC licence, not converted from a unit scale. Asking how many mg is 70 units of tirzepatide is a bit like asking how many litres is 70 miles: the units belong to different systems entirely.

In the licensed Mounjaro KwikPen, tirzepatide is dissolved in a solution at a known concentration, but that concentration is irrelevant to the patient because the pen mechanism handles delivery. For a breakdown of how the milligram doses translate to the solution volume in each injection, the Mounjaro SmPC on the eMC sets this out in the pharmaceutical particulars, it's technical reading aimed at healthcare professionals, but it's publicly accessible.

If you're trying to cross-reference a 2.5 mg starting dose with the volume delivered, the page covering how many units 2.5 mg of tirzepatide represents addresses that specific question directly.

The licensed dose schedule, and why titration isn't a patient decision

Treatment with Mounjaro starts at 2.5 mg once weekly. That dose is a tolerability step: the job of the first pen is to let your system adjust, not to deliver full therapeutic effect. From there, a prescriber typically increases by one step every four weeks or so, guided by how you're tolerating the current dose and your clinical picture. The ceiling is 15 mg.

That schedule (2.5, 5, 7.5, 10, 12.5, 15 mg) is what NICE reviewed when appraising tirzepatide in TA1026 and what the clinical trial programme tested. SURMOUNT-1, which randomised over 2,500 adults with obesity, found average body-weight reductions of around 20–21% at the 15 mg maintenance dose over 72 weeks. Those results were achieved through the licensed titration route, not through patients self-adjusting doses.

This matters for the units question. Someone wondering whether 70 units equals a particular mg dose may be trying to self-calculate an adjustment. That's not how Mounjaro works, and it's not something a prescriber would want a patient attempting. If you feel your current dose isn't working or side effects are making it hard to continue, that's a clinical conversation, the kind that happens through a consultation with our prescribers.

For reference, the 5 mg dose (one step up from the starter) has its own breakdown of what that pen delivers, on the page about how many units 5 mg of tirzepatide is. Each dose step in the Mounjaro range has a fixed, pre-set delivery mechanism; none of them involve the patient measuring anything in units. If you've already worked through the earlier steps and want to understand the next stages, the page explaining how many units 7.5 mg of tirzepatide corresponds to covers that dose in the same way, and the pages on what 10 units of tirzepatide works out to in mg and what 30 units of tirzepatide works out to in mg address those common conversion queries directly.

What to do if you have a genuine question about your dose

Dose questions come up a lot. Prescribers hear them most weeks: someone's pen looks different from last month's, a pharmacist abroad used different terminology, a family member on insulin is trying to help and introduced the units concept. None of that is unusual, and the question deserves a direct answer rather than a vague brush-off.

The right route is your prescriber, not a unit-conversion table. If you're already on Mounjaro and something has changed or feels unclear, the FAQs cover common practical questions, and our aftercare team is available seven days a week through the contact page. If you're still deciding whether Mounjaro is right for you and want to understand how doses work in practice, the Mounjaro overview lays out the full picture (mechanism, schedule, evidence and eligibility) in plain language.

One practical note: if you're planning to start treatment and you're timing your order around a particular week (a long weekend, a bank holiday, or simply wanting it to arrive before a certain date) orders placed before 12pm on a working day go out the same day once clinically approved, with free next-working-day tracked delivery. Worth factoring in if timing matters.

For anyone weighing up the broader treatment landscape, the weight-loss treatment overview sets out what's licensed in the UK and how the options compare. The clinical team profile on our clinical lead's page gives a sense of who reviews consultations.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions